Conestoga Capital Advisors, LLC Merck & Co., Inc. Transaction History

Conestoga Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $183,775 - $206,000	2,500 New	2,500 $205,000
Q1 2021 Apr 23, 2021	SELL	$68.86 - $81.11 $457,919 - $539,381	-6,650 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $16,309 - $18,927	-250 Reduced 3.62%	6,650 $508,000
Q4 2017 Jan 22, 2018	SELL	$51.62 - $61.64 $36,134 - $43,148	-700 Reduced 9.21%	6,900 $388,000
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $445,892 - $479,788	7,600	7,600 $487,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.